DNA methylation patterns of protein coding genes and long noncoding RNAs in female schizophrenic patients

European Journal of Medical Genetics

Volumn 58, Issue 2, 2015, Pages 95-104

  Liao, Qi ^a   Wang, Yunliang ^b   Cheng, Jia ^c   Dai, Dongjun ^a   Zhou, Xingyu ^a   Zhang, Yuzheng ^b   Gao, Shugui ^c   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b The 148 Central Hospital of PLA   (China)

^c Ningbo Kangning Hospital   (China)

Author keywords

DNA methylation; Epigenetic; Long noncoding RNAs (lncRNAs); Schizophrenia (SCZ)

Indexed keywords

LONG UNTRANSLATED RNA; METHYL CPG BINDING PROTEIN;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DSM-IV; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE ONTOLOGY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; HIGH THROUGHPUT SEQUENCING; HUMAN; NEXT GENERATION SEQUENCING; PARANOID SCHIZOPHRENIA; PATTERN RECOGNITION; PROMOTER REGION; SCHIZOPHRENIA; UNDIFFERENTIATED SCHIZOPHRENIA; X CHROMOSOME; X CHROMOSOME INACTIVATION; YOUNG ADULT; GENETICS;

ADULT; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE ONTOLOGY; HUMANS; PROMOTER REGIONS, GENETIC; RNA, LONG NONCODING; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84923292522     PISSN: 17697212     EISSN: 18780849     Source Type: Journal    
DOI: 10.1016/j.ejmg.2014.12.001     Document Type: Article

References (79)

1. Abdolmaleky H.M., Cheng K.H., Faraone S.V., Wilcox M., Glatt S.J., Gao F., et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 2006, 15:3132-3145.
2. Abdolmaleky H.M., Cheng K.H., Russo A., Smith C.L., Faraone S.V., Wilcox M., et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005, 134B:60-66.
3. Abdolmaleky H.M., Thiagalingam S. Can the schizophrenia epigenome provide clues for the molecular basis of pathogenesis?. Epigenomics 2011, 3:679-683.
4. Abel K.M., Drake R., Goldstein J.M. Sex differences in schizophrenia. Int Rev Psychiatry 2010, 22:417-428.
5. Bae J.S., Pasaje C.F., Park B.L., Cheong H.S., Kim J.H., Kim J.Y., et al. Genetic association analysis of ERBB4 polymorphisms with the risk of schizophrenia and SPEM abnormality in a Korean population. Brain Res 2012, 1466:146-151.
6. Banerjee A., Macdonald M.L., Borgmann-Winter K.E., Hahn C.G. Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome. Brain Res Bull 2010, 83:132-139.
7. Buonanno A. The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits. Brain Res Bull 2010, 83:122-131.
8. Chen G., Yin K., Shi L., Fang Y., Qi Y., Li P., et al. Comparative analysis of human protein-coding and noncoding RNAs between brain and 10 mixed cell lines by RNA-Seq. PLoS One 2011, 6:e28318.
9. Cheng M.C., Lu C.L., Luu S.U., Tsai H.M., Hsu S.H., Chen T.T., et al. Genetic and functional analysis of the DLG4 gene encoding the post-synaptic density protein 95 in schizophrenia. PLoS One 2010, 5:e15107.
10. Chiesa N., De Crescenzo A., Mishra K., Perone L., Carella M., Palumbo O., et al. The KCNQ1OT1 imprinting control region and non-coding RNA: new properties derived from the study of Beckwith-Wiedemann syndrome and Silver-Russell syndrome cases. Hum Mol Genet 2012, 21:10-25.
11. Connor C.M., Akbarian S. DNA methylation changes in schizophrenia and bipolar disorder. Epigenetics 2008, 3:55-58.
12. Cunningham D., Atkin W., Lenz H.J., Lynch H.T., Minsky B., Nordlinger B., et al. Colorectal cancer. Lancet 2010, 375:1030-1047.
13. Deaton A.M., Bird A. CpG islands and the regulation of transcription. Genes Dev 2011, 25:1010-1022.
14. Derrien T., Johnson R., Bussotti G., Tanzer A., Djebali S., Tilgner H., et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012, 22:1775-1789.
15. Du J., Xu Y., Duan S., Zhang A., Xuan J., Wang L., et al. A case-control association study between the CYP3A4 and CYP3A5 genes and schizophrenia in the Chinese Han population. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1200-1204.
16. Faghihi M.A., Modarresi F., Khalil A.M., Wood D.E., Sahagan B.G., Morgan T.E., et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 2008, 14:723-730.
17. Fanous A.H., Kendler K.S. Genetics of clinical features and subtypes of schizophrenia: a review of the recent literature. Curr Psychiatry Rep 2008, 10:164-170.
18. Favre G., Banta Lavenex P., Lavenex P. Developmental regulation of expression of schizophrenia susceptibility genes in the primate hippocampal formation. Transl Psychiatry 2012, 2:e173.
19. Funk A.J., Rumbaugh G., Harotunian V., McCullumsmith R.E., Meador-Woodruff J.H. Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia. Neuroreport 2009, 20:1019-1022.
20. Gao S., Hu Z., Cheng J., Zhou W., Xu Y., Xie S., et al. Impact of catechol-o-methyltransferase polymorphisms on risperidone treatment for schizophrenia and its potential clinical significance. Clin Biochem 2012, 45:787-792.
21. Garding A., Bhattacharya N., Claus R., Ruppel M., Tschuch C., Filarsky K., et al. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB. PLoS Genet 2013, 9:e1003373.
22. Gavin D.P., Sharma R.P. Histone modifications, DNA methylation, and schizophrenia. Neurosci Biobehav Rev 2010, 34:882-888.
23. Goto T., Monk M. Regulation of X-chromosome inactivation in development in mice and humans. Microbiol Mol Biol Rev 1998, 62:362-378.
24. Grayson D.R., Jia X., Chen Y., Sharma R.P., Mitchell C.P., Guidotti A., et al. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A 2005, 102:9341-9346.
25. Hall M.H., Schulze K., Rijsdijk F., Picchioni M., Ettinger U., Bramon E., et al. Heritability and reliability of P300, P50 and duration mismatch negativity. Behav Genet 2006, 36:845-857.
26. Heinz S., Benner C., Spann N., Bertolino E., Lin Y.C., Laslo P., et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 2010, 38:576-589.
27. Hogart A., Lichtenberg J., Ajay S.S., Anderson S., Margulies E.H., Bodine D.M. Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites. Genome Res 2012, 22:1407-1418.
28. Hu Zhi-Liang, Bao J., Reecy J.M. CateGOrizer: A Web-Based Program to Batch Analyze Gene Ontology Classification Categories. Online Journal of Bioinformatics 2008, 9:108-112.
29. Ibala-Romdhane S., Al-Khtib M., Khoueiry R., Blachere T., Guerin J.F., Lefevre A. Analysis of H19 methylation in control and abnormal human embryos, sperm and oocytes. Eur J Hum Genet 2011, 19:1138-1143.
30. Ikegame T., Bundo M., Sunaga F., Asai T., Nishimura F., Yoshikawa A., et al. DNA methylation analysis of BDNF gene promoters in peripheral blood cells of schizophrenia patients. Neurosci Res 2013, 77:208-214.
31. Iwamoto K., Bundo M., Yamada K., Takao H., Iwayama-Shigeno Y., Yoshikawa T., et al. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci 2005, 25:5376-5381.
32. Jablensky A., Morar B., Wiltshire S., Carter K., Dragovic M., Badcock J.C., et al. Polymorphisms associated with normal memory variation also affect memory impairment in schizophrenia. Genes Brain Behav 2011, 10:410-417.
33. Johnson R. Long non-coding RNAs in Huntington's disease neurodegeneration. Neurobiol Dis 2012, 46:245-254.
34. Kahler A.K., Djurovic S., Kulle B., Jonsson E.G., Agartz I., Hall H., et al. Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1089-1100.
35. Karolchik D., Hinrichs A.S., Furey T.S., Roskin K.M., Sugnet C.W., Haussler D., et al. The UCSC Table Browser data retrieval tool. Nucleic Acids Res 2004, 32:D493-D496.
36. Kordi-Tamandani D.M., Vaziri S., Dahmardeh N., Torkamanzehi A. Evaluation of polymorphism, hypermethylation and expression pattern of CTLA4 gene in a sample of Iranian patients with schizophrenia. Mol Biol Rep 2013, 40:5123-5128.
37. Korneev S.A., Straub V., Kemenes I., Korneeva E.I., Ott S.R., Benjamin P.R., et al. Timed and targeted differential regulation of nitric oxide synthase (NOS) and anti-NOS genes by reward conditioning leading to long-term memory formation. J Neurosci 2005, 25:1188-1192.
38. Kristiansen L.V., Patel S.A., Haroutunian V., Meador-Woodruff J.H. Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia. Synapse 2010, 64:495-502.
39. Lai C.Y., Yu S.L., Hsieh M.H., Chen C.H., Chen H.Y., Wen C.C., et al. MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One 2011, 6:e21635.
40. Lan X., Adams C., Landers M., Dudas M., Krissinger D., Marnellos G., et al. High resolution detection and analysis of CpG dinucleotides methylation using MBD-Seq technology. PLoS One 2011, 6:e22226.
41. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009, 10:R25.
42. Li D., Feng J., Wu T., Wang Y., Sun Y., Ren J., et al. Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma. Am J Pathol 2013, 182:64-70.
43. Lindamer L.A., Lohr J.B., Harris M.J., Jeste D.V. Gender, estrogen, and schizophrenia. Psychopharmacol Bull 1997, 33:221-228.
44. Lionel A.C., Vaags A.K., Sato D., Gazzellone M.J., Mitchell E.B., Chen H.Y., et al. Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures. Hum Mol Genet 2013, 22:2055-2066.
45. Lu C.L., Wang Y.C., Chen J.Y., Lai I.C., Liou Y.J. Support for the involvement of the ERBB4 gene in schizophrenia: a genetic association analysis. Neurosci Lett 2010, 481:120-125.
46. Luo X.J., Li M., Huang L., Steinberg S., Mattheisen M., Liang G., et al. Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene. Mol Psychiatry 2014, 19:774-783.
47. Mancini-Dinardo D., Steele S.J., Levorse J.M., Ingram R.S., Tilghman S.M. Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genes. Genes Dev 2006, 20:1268-1282.
48. Mandemakers W., Morais V.A., De Strooper B. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases. J Cell Sci 2007, 120:1707-1716.
49. Melas P.A., Rogdaki M., Osby U., Schalling M., Lavebratt C., Ekstrom T.J. Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB J 2012, 26:2712-2718.
50. Mellios N., Galdzicka M., Ginns E., Baker S.P., Rogaev E., Xu J., et al. Gender-specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia. Schizophr Bull 2012, 38:433-443.
51. Mercer T.R., Dinger M.E., Sunkin S.M., Mehler M.F., Mattick J.S. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci U S A 2008, 105:716-721.
52. Millar J.K., James R., Brandon N.J., Thomson P.A. DISC1 and DISC2: discovering and dissecting molecular mechanisms underlying psychiatric illness. Ann Med 2004, 36:367-378.
53. Momeni P., Wickremaratchi M.M., Bell J., Arnold R., Beer R., Hardy J., et al. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia. Clin Neurol Neurosurg 2010, 112:917-920.
54. Nakato R., Itoh T., Shirahige K. DROMPA: easy-to-handle peak calling and visualization software for the computational analysis and validation of ChIP-seq data. Genes Cells 2013, 18:589-601.
55. Nohesara S., Ghadirivasfi M., Mostafavi S., Eskandari M.R., Ahmadkhaniha H., Thiagalingam S., et al. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J Psychiatr Res 2011, 45:1432-1438.
56. O'Dushlaine C., Kenny E., Heron E., Donohoe G., Gill M., Morris D., et al. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 2011, 16:286-292.
57. Ohnuma T., Kato H., Arai H., Faull R.L., McKenna P.J., Emson P.C. Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. Neuroreport 2000, 11:3133-3137.
58. Okazaki Y., Furuno M., Kasukawa T., Adachi J., Bono H., Kondo S., et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 2002, 420:563-573.
59. Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., et al. Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet 2004, 36:40-45.
60. Pang K.C., Dinger M.E., Mercer T.R., Malquori L., Grimmond S.M., Chen W., et al. Genome-wide identification of long noncoding RNAs in CD8+ T cells. J Immunol 2009, 182:7738-7748.
61. Pun F.W., Zhao C., Lo W.S., Ng S.K., Tsang S.Y., Nimgaonkar V., et al. Imprinting in the schizophrenia candidate gene GABRB2 encoding GABA(A) receptor beta(2) subunit. Mol Psychiatry 2011, 16:557-568.
62. Qu C., Jiang T., Li Y., Wang X., Cao H., Xu H., et al. Gene expression and IG-DMR hypomethylation of maternally expressed gene 3 in developing corticospinal neurons. Gene Expr Patterns 2013, 13:51-56.
63. Rosenbloom K.R., Sloan C.A., Malladi V.S., Dreszer T.R., Learned K., Kirkup V.M., et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res 2013, 41:D56-63.
64. Sharma R.P., Grayson D.R., Gavin D.P. Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr Res 2008, 98:111-117.
65. Sinkkonen L., Hugenschmidt T., Berninger P., Gaidatzis D., Mohn F., Artus-Revel C.G., et al. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat Struct Mol Biol 2008, 15:259-267.
66. Sleutels F., Zwart R., Barlow D.P. The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature 2002, 415:810-813.
67. Stefanis N.C., Hatzimanolis A., Smyrnis N., Avramopoulos D., Evdokimidis I., van Os J., et al. Schizophrenia candidate gene ERBB4: covert routes of vulnerability to psychosis detected at the population level. Schizophr Bull 2013, 39:349-357.
68. Sun J., Wan C., Jia P., Fanous A.H., Kendler K.S., Riley B.P., et al. Application of systems biology approach identifies and validates GRB2 as a risk gene for schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. Schizophr Res 2011, 125:201-208.
69. Taft R.J., Pang K.C., Mercer T.R., Dinger M., Mattick J.S. Non-coding RNAs: regulators of disease. J Pathol 2010, 220:126-139.
70. Taylor J.M., Brody K.M., Lockhart P.J. Parkin co-regulated gene is involved in aggresome formation and autophagy in response to proteasomal impairment. Exp Cell Res 2012, 318:2059-2070.
71. Taylor J.M., Song Y.J., Huang Y., Farrer M.J., Delatycki M.B., Halliday G.M., et al. Parkin Co-Regulated Gene (PACRG) is regulated by the ubiquitin-proteasomal system and is present in the pathological features of Parkinsonian diseases. Neurobiol Dis 2007, 27:238-247.
72. Tolosa A., Sanjuan J., Dagnall A.M., Molto M.D., Herrero N., de Frutos R. FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies. BMC Med Genet 2010, 11:114.
73. Underwood S.L., Christoforou A., Thomson P.A., Wray N.R., Tenesa A., Whittaker J., et al. Association analysis of the chromosome 4p-located G protein-coupled receptor 78 (GPR78) gene in bipolar affective disorder and schizophrenia. Mol Psychiatry 2006, 11:384-394.
74. Wang K.S., Liu X.F., Aragam N. A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder. Schizophr Res 2010, 124:192-199.
75. Wilson G.R., Tan J.T., Brody K.M., Taylor J.M., Delatycki M.B., Lockhart P.J. Expression and localization of the Parkin co-regulated gene in mouse CNS suggests a role in ependymal cilia function. Neurosci Lett 2009, 460:97-101.
76. Wilusz J.E., Sunwoo H., Spector D.L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009, 23:1494-1504.
77. Xie Y., Yao Z., Chai H., Wong W.M., Wu W. Potential roles of Alzheimer precursor protein A4 and beta-amyloid in survival and function of aged spinal motor neurons after axonal injury. J Neurosci Res 2003, 73:557-564.
78. Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol 2008, 9:R137.
79. Zhang Z., Kageyama Y., Sesaki H. Mitochondrial division prevents neurodegeneration. Autophagy 2012, 8:1531-1533.